Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tipr Pharmaceutical, formally known as Tianjin Institute of Pharmaceutical Research Pharmaceutical Co., Ltd., is a China-based pharmaceutical company that originated from the Tianjin Institute of Pharmaceutical Research. The company specializes in the research, development, and manufacturing of a wide range of pharmaceutical products, including chemical drugs and modern Traditional Chinese Medicines (TCM). Its product portfolio covers several therapeutic areas such as cardiovascular and cerebrovascular diseases, anti-infectives, and oncology. Tipr Pharmaceutical operates as a comprehensive enterprise integrating R&D, production, and sales, leveraging its historical roots in pharmaceutical research to maintain a robust pipeline of generic and innovative treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tipr Pharmaceutical.